Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

Withdrawn before enrolling · Phase 4

Conditions studied: Estrogen, Menopause, Pelvic Floor Disorders, Surgery

In brief

PURPOSE: To evaluate patient adherence to cream versus tablet based local estrogen therapy by randomizing treatment modalities to determine differences in adherence to either form. HYPOTHESIS: There is no difference in adherence to cream versus tablet based local estrogen therapy when prescribed as a 6 week course of postoperative therapy after female pelvic reconstructive surgery.

Key facts

Study ID

NCT02860897

Run by

University Hospitals Cleveland Medical Center

People needed

0

Starts

2016-07-01

Expected to finish

2017-07-01

Last updated by the study team

2018-05-02

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patients who underwent female pelvic reconstructive surgery at University Hospitals Case Medical Center and were given postoperative local estrogen therapy.
• Patients who consented to the study.
• Postmenopausal

You may not qualify if…

• Patients who were not given a prescription for postoperative lower estrogen therapy despite undergoing surgery.
• Patients with contraindications to vaginal estrogen.
• Any obliterative procedures. Patients who are unable to participate in informed consent. Patients younger than 18. Non English speaking patients

Where it is running

• University Hospitals Case Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.